| Non-NB cases (4797) | NB cases (252) | p |
Diabetes | 1001 | 75 | Â |
Rate (%) | 20.9 | 29.8 | Â |
Model 1 | 1 (Ref.) | 1.61 (1.22–2.12) | 0.001 |
Model 2 | 1 (Ref.) | 1.45 (1.26–1.68) | 0.010 |
Model 3 | 1 (Ref.) | 1.44 (1.24–1.67) | 0.014 |
Model 4 | 1 (Ref.) | 1.41 (1.06–1.89) | 0.021 |
Sensitivity analysis* | Non-NB cases (4744) | NB cases (250) | Â |
Diabetes | 990 | 75 | Â |
Rate (%) | 20.9 | 29.8 | Â |
Model 1 | 1 (Ref.) | 1.59 (1.20–2.11) | 0.001 |
Model 2 | 1 (Ref.) | 1.45 (1.09–1.92) | 0.012 |
Model 3 | 1 (Ref.) | 1.43 (1.06–1.91) | 0.018 |
Model 4 | 1 (Ref.) | 1.40 (1.04–1.87) | 0.026 |